• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中桡动脉的组织学和免疫组织化学表现提示钙化与早期动脉粥样硬化病变之间存在相互作用。

Histology and Immunohistochemistry of Radial Arteries Are Suggestive of an Interaction between Calcification and Early Atherosclerotic Lesions in Chronic Kidney Disease.

机构信息

Department of Nephrology, Papageorgiou General Hospital, 56429 Thessaloniki, Greece.

Department of Orhtopediscs, Papanikolaou General Hospital, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece.

出版信息

Medicina (Kaunas). 2021 Oct 24;57(11):1156. doi: 10.3390/medicina57111156.

DOI:10.3390/medicina57111156
PMID:34833374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8619577/
Abstract

: recent studies suggest an implication of immune mechanisms in atherosclerotic disease. In this paper, the interaction between inflammation, calcification, and atherosclerosis on the vessel walls of patients with chronic kidney disease (CKD) is described and evaluated. : patients with stage V CKD, either on pre-dialysis (group A) or on hemodialysis (HD) for at least 2 years (group B), in whom a radiocephalic arteriovenous fistula (RCAVF) was created, were included in the study. The control group included healthy volunteers who received radial artery surgery after an accident. The expressions of inflammatory cells, myofibroblasts, and vascular calcification regulators on the vascular wall were estimated, and, moreover, morphometric analysis was performed. : the expressions of CD68(+) cells, matrix carboxyglutamic acid proteins (MGPs), the receptor activator of nuclear factor-kB (RANK) and RANK ligand (RANKL), and osteoprotegerin (OPG), were significantly increased in CKD patients compared to the controls = 0.02; = 0.006; = 0.01; and = 0.006, respectively. In morphometric analysis, the I/M and L/I ratios had significant differences between CKD patients and the controls 0.3534 ± 0.20 vs. 0.1520 ± 0.865, = 0.003, and 2.1709 ± 1.568 vs. 4.9958 ± 3.2975, = 0.03, respectively. The independent variables correlated with the degree of vascular calcification were the intensity of CD34(+), aSMA(+) cells, and OPG, R = 0.76, < 0.0001, and, with intima-media thickness (IMT), the severity of RANKL expression R = 0.3, < 0.0001. : atherosclerosis and vascular calcification in CKD seem to be strongly regulated by an immunological and inflammatory activation on the vascular wall.

摘要

: 最近的研究表明,免疫机制在动脉粥样硬化疾病中起作用。本文描述并评估了慢性肾脏病(CKD)患者血管壁的炎症、钙化和动脉粥样硬化之间的相互作用。: 该研究纳入了 5 期 CKD 患者,包括在透析前(A 组)或至少接受 2 年血液透析(HD)(B 组)的患者,在这些患者中建立了头静脉桡动脉动静脉瘘(RCAVF)。对照组包括因意外接受桡动脉手术后的健康志愿者。估计了血管壁上炎症细胞、肌纤维母细胞和血管钙化调节剂的表达,并进行了形态计量学分析。: 与对照组相比,CKD 患者的 CD68(+)细胞、基质羧基谷氨酸蛋白(MGPs)、核因子-kB 受体激活剂(RANK)和 RANK 配体(RANKL)以及骨保护素(OPG)的表达显著增加 = 0.02; = 0.006; = 0.01;和 = 0.006,分别。在形态计量学分析中,CKD 患者和对照组之间的 I/M 和 L/I 比值有显著差异 0.3534 ± 0.20 vs. 0.1520 ± 0.865, = 0.003,和 2.1709 ± 1.568 vs. 4.9958 ± 3.2975, = 0.03,分别。与血管钙化程度相关的独立变量是 CD34(+)、aSMA(+)细胞和 OPG 的强度,R = 0.76, < 0.0001,与内膜中层厚度(IMT)相关的变量是 RANKL 表达的严重程度,R = 0.3, < 0.0001。: CKD 中的动脉粥样硬化和血管钙化似乎受到血管壁上免疫和炎症激活的强烈调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/0e392e656f72/medicina-57-01156-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/a49a9a463284/medicina-57-01156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/937e54935dc8/medicina-57-01156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/18897ff42d9e/medicina-57-01156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/0e392e656f72/medicina-57-01156-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/a49a9a463284/medicina-57-01156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/937e54935dc8/medicina-57-01156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/18897ff42d9e/medicina-57-01156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2b/8619577/0e392e656f72/medicina-57-01156-g004.jpg

相似文献

1
Histology and Immunohistochemistry of Radial Arteries Are Suggestive of an Interaction between Calcification and Early Atherosclerotic Lesions in Chronic Kidney Disease.慢性肾脏病中桡动脉的组织学和免疫组织化学表现提示钙化与早期动脉粥样硬化病变之间存在相互作用。
Medicina (Kaunas). 2021 Oct 24;57(11):1156. doi: 10.3390/medicina57111156.
2
Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.严重动脉钙化的血液透析患者血浆中骨保护素水平升高。
Ther Apher Dial. 2018 Oct;22(5):519-529. doi: 10.1111/1744-9987.12681. Epub 2018 Jul 4.
3
Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries.慢性肾脏病患者的心血管风险:内膜中层厚度可预测经组织学评估的桡动脉中层钙化的发生率和严重程度。
BMC Nephrol. 2015 Jun 3;16:78. doi: 10.1186/s12882-015-0067-8.
4
FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.在血液透析患者中,成纤维细胞生长因子23(FGF - 23)水平与血管钙化相关,但与动脉粥样硬化无关。
Int Urol Nephrol. 2016 Apr;48(4):609-17. doi: 10.1007/s11255-016-1231-1. Epub 2016 Feb 10.
5
Soluble TWEAK level: is it a marker for cardiovascular disease in long-term hemodialysis patients?可溶性 TWEAK 水平:它是长期血液透析患者心血管疾病的标志物吗?
J Nephrol. 2013 Jan-Feb;26(1):136-43. doi: 10.5301/jn.5000121.
6
Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5.维生素K2对3-5期非透析慢性肾病患者动脉粥样硬化进展及血管钙化的影响
Pol Arch Med Wewn. 2015;125(9):631-40. doi: 10.20452/pamw.3041. Epub 2015 Jul 15.
7
Asymmetric dimethylarginine as a useful risk marker of radial artery calcification in patients with advanced kidney disease.不对称二甲基精氨酸作为晚期肾病患者桡动脉钙化的有用风险标志物。
Pol Arch Intern Med. 2018 Mar 29;128(3):157-165. doi: 10.20452/pamw.4201. Epub 2018 Feb 6.
8
Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis.系统性硬化症中骨保护素/核因子-κB配体受体激活剂系统与炎症和动脉粥样硬化相关性的研究
Immunol Invest. 2018 Apr;47(3):241-250. doi: 10.1080/08820139.2017.1423499. Epub 2018 Jan 16.
9
Vascular inflammation and media calcification are already present in early stages of chronic kidney disease.血管炎症和中膜钙化在慢性肾脏病早期就已存在。
Cardiovasc Pathol. 2017 Mar-Apr;27:57-67. doi: 10.1016/j.carpath.2017.01.004. Epub 2017 Jan 23.
10
Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease.在3至5期慢性肾脏病患者中,血浆骨保护素水平升高与全因死亡风险及动脉粥样硬化相关。
Braz J Med Biol Res. 2014 Nov;47(11):995-1002. doi: 10.1590/1414-431x20144007. Epub 2014 Aug 22.

引用本文的文献

1
Prospective Analysis of B Lymphocyte Subtypes, before and after Initiation of Dialysis, in Patients with End-Stage Renal Disease.终末期肾病患者透析开始前后B淋巴细胞亚群的前瞻性分析
Life (Basel). 2023 Mar 23;13(4):860. doi: 10.3390/life13040860.
2
Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis.血清骨保护素和核因子κB受体活化因子配体水平作为血液透析终末期肾病患者心血管钙化发生的危险因素
Life (Basel). 2023 Feb 6;13(2):454. doi: 10.3390/life13020454.

本文引用的文献

1
Circulating Levels of Dephosphorylated-Uncarboxylated Matrix Gla Protein in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者中去磷酸化未羧化基质 Gla 蛋白的循环水平。
Molecules. 2021 Feb 19;26(4):1108. doi: 10.3390/molecules26041108.
2
T cell markers recount the course of immunosenescence in healthy individuals and chronic kidney disease.T 细胞标志物可追溯健康个体和慢性肾病的免疫衰老过程。
Clin Immunol. 2021 Apr;225:108685. doi: 10.1016/j.clim.2021.108685. Epub 2021 Feb 4.
3
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
慢性肾脏病中的血管病变:病理生理机制和新的治疗方法。
J Mol Med (Berl). 2021 Mar;99(3):335-348. doi: 10.1007/s00109-021-02037-7. Epub 2021 Jan 22.
4
Influence of end stage renal disease on CD28 expression and T-cell immunity.终末期肾病对 CD28 表达和 T 细胞免疫的影响。
Nephrology (Carlton). 2021 Feb;26(2):185-196. doi: 10.1111/nep.13784. Epub 2020 Sep 28.
5
Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.慢性肾脏病中的内皮损伤、炎症与免疫
Toxins (Basel). 2020 Jun 1;12(6):361. doi: 10.3390/toxins12060361.
6
RANKL biology: bone metabolism, the immune system, and beyond.核因子κB受体活化因子配体生物学:骨代谢、免疫系统及其他领域
Inflamm Regen. 2020 Feb 7;40:2. doi: 10.1186/s41232-019-0111-3. eCollection 2020.
7
Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis.年龄相关的线粒体功能障碍加速动脉粥样硬化形成。
Circ Res. 2020 Jan 31;126(3):298-314. doi: 10.1161/CIRCRESAHA.119.315644. Epub 2019 Dec 9.
8
Pathogenesis and management of vascular calcification in CKD and dialysis patients.慢性肾脏病及透析患者血管钙化的发病机制与管理
Semin Dial. 2019 Nov;32(6):553-561. doi: 10.1111/sdi.12840. Epub 2019 Aug 29.
9
Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?慢性肾脏病中的动脉粥样硬化:更多、更少,还是仅仅不同?
Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1938-1966. doi: 10.1161/ATVBAHA.119.312705. Epub 2019 Aug 15.
10
The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts.慢性肾脏病(CKD)中矿物质代谢、血管钙化与炎症之间的相互作用:用新事实挑战旧观念。
Aging (Albany NY). 2019 Jun 26;11(12):4274-4299. doi: 10.18632/aging.102046.